Drug Shortage Report for CYTARABINE INJECTION
| Report ID | 1059 |
| Drug Identification Number | 02126656 |
| Brand name | CYTARABINE INJECTION |
| Common or Proper name | CYTARABINE |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CYTARABINE |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRATHECAL INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 1g/mL X 10 |
| ATC code | L01BC |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2013-06-15 |
| Actual start date | 2013-06-15 |
| Estimated end date | Unknown |
| Actual end date | 2017-09-20 |
| Shortage status | Resolved |
| Updated date | 2017-10-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-13 | English | Compare |
| v2 | 2017-03-13 | French | Compare |
| v3 | 2017-10-13 | English | Compare |
| v4 | 2017-10-13 | French | Compare |
Showing 1 to 4 of 4